V

Vesa Kataja

Kuopio University Hospital

ORCID: 0000-0003-4846-4843

Publishes on BRCA gene mutations in cancer, Breast Cancer Treatment Studies, Prostate Cancer Treatment and Research. 337 papers and 27.4k citations.

PubIndex Score98Top 2%How it's scored

337Publications

27.4kTotal Citations

First publication: 1984First senior author: 1993

BRCA gene mutations in cancer Breast Cancer Treatment Studies Prostate Cancer Treatment and Research HER2/EGFR in Cancer Research Estrogen and related hormone effects

Top publicationsby citations

Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer

Heikki Joensuu, Jorma Isola, Pirkko‐Liisa Kellokumpu‐Lehtinen et al.|New England Journal of Medicine|2006

Cited by 1.4k

Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial

Sherene Loi, Christos Sotiriou, Stefan Michiels et al.|Annals of Oncology|2014

Cited by 1.3k

Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Alan Horwich, Vesa Kataja, C. Bangma et al.|Annals of Oncology|2010

Cited by 600

A recurrent mutation in PALB2 in Finnish cancer families

Hannele Erkko, Robert Winqvist, Bing Xia et al.|Nature|2007

Cited by 461

Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer Trial

Heikki Joensuu, Pirkko‐Liisa Kellokumpu‐Lehtinen, Petri Bono et al.|Journal of Clinical Oncology|2009

Cited by 459